INVOX PHARMA LIMITED
Get an alert when INVOX PHARMA LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-03-05 (in 10mo)
Last made up 2026-02-19
Watchouts
None on the register
Cash
£128K
+208.5% vs 2023
Net assets
-£36M
-98.3% vs 2023
Employees
99
+110.6% vs 2023
Profit before tax
-£18M
-86.2% vs 2023
Name history
Renamed 1 time since incorporation
- INVOX PHARMA LIMITED 2021-06-07 → present
- C-LAB INTERNATIONAL LIMITED 2021-03-12 → 2021-06-07
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£8,645,326 | -£6,123,684 | |
| Profit before tax | -£9,648,183 | -£17,962,658 | |
| Net profit | -£9,662,373 | -£18,015,880 | |
| Cash | £41,451 | £127,861 | |
| Total assets less current liabilities | — | — | |
| Net assets | -£18,323,269 | -£36,333,241 | |
| Equity | -£18,323,269 | -£36,333,241 | |
| Average employees | 47 | 99 | |
| Wages | £947,018 | £2,178,011 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Gearing (liabilities / total assets) | 219.3% | 213.0% | |
| Current ratio | -0.13x | -0.13x | |
| Interest cover | -2365.99x | -16.66x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have a reasonable expectation that the group has adequate resources to continue in operational existence for at least 12 months. Thus, the directors continue to adopt the going concern basis of accounting in preparing the financial statements.”
Significant events
- “On 1 January 2025, the company reassigned its lease of laboratory space in Cambridge. From this date, all rights, obligations and benefits associated with the original lease agreement were passed to an external party.”
- “On 2 April 2025, F-star Therapeutics Limited, a subsidiary of F-star Therapeutics, Inc. was sold to the existing management team of F-star Therapeutics Limited for an undisclosed amount.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 3 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DUONG, Philip | Director | 2024-12-02 | Dec 1990 | Canadian |
| TSE, Eric | Director | 2024-12-02 | Aug 1995 | Chinese |
| TSE, Ping | Director | 2023-05-09 | Jan 1952 | Chinese |
Show 3 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HUSSEY, Tyron Anthony | Secretary | 2021-08-31 | 2024-11-27 |
| TOOGOOD, Benjamin | Director | 2021-03-12 | 2024-11-26 |
| TSE, Theresa Y Y | Director | 2021-03-18 | 2024-12-11 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 26 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-11-11 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-11-11 | RESOLUTIONS | resolution | Resolution | |
| 2025-10-07 | AA | accounts | Accounts with accounts type full | |
| 2025-03-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-01-06 | AA | accounts | Accounts with accounts type full | |
| 2024-12-12 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-12-04 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-27 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-11-26 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-19 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-01-06 | AA | accounts | Accounts with accounts type small | |
| 2023-05-11 | AA | accounts | Accounts with accounts type small | |
| 2023-05-09 | AP01 | officers | Appoint person director company with name date | |
| 2023-03-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-03-16 | CH01 | officers | Change person director company with change date | |
| 2023-03-13 | CH03 | officers | Change person secretary company with change date | |
| 2023-02-01 | AD01 | address | Change registered office address company with date old address new address | |
| 2022-03-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-01 | CH01 | officers | Change person director company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
+208.5%
£41,451 £127,861
-
Net assets
-98.3%
-£18,323,269 -£36,333,241
-
Employees
+110.6%
47 99
-
Operating profit
+29.2%
-£8,645,326 -£6,123,684
-
Profit before tax
-86.2%
-£9,648,183 -£17,962,658
-
Wages
+130%
£947,018 £2,178,011
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers